\-\ Texto\\:\\ \ \(0\)\
\-\ physical\\ examination\\:\\ patient\\ has\\ pain\\ with\\ ambulation\\.\\ knees\\ \\ no\\ pain\\ to\\ palpation\\,\\ no\\ nodules\\,\\ no\\ muscle\\ weakness\\,\\ no\\ warmth\\ to\\ touch\\,\\ no\\ erythema\\.\\ \\ \ \(0\)\
\-\ \\(lt\\ knee\\)\\:\\ full\\ rom\\.\\ \\ \ \(0\)\
\-\ \\(rt\\ knee\\)\\:some\\ generalized\\ swelling\\,\\ \\+\\ pain\\ with\\ extension\\,\\ decreased\\ rom\\ secondary\\ to\\ pain\ \(0\)\
\-\ pertinent\\ laboratory\\ studies\\ showed\\ esr\\ 65\\ \\(h\\)\\,\\ ana\\ \\(\\-\\)\\,\\ rheumatoid\\ factor\\ 10\\.8\\ \\(0\\-14\\)\\,\\ urate\\ 4\\.3\\,\\ c\\-reactive\\ protein\\ 0\\.219\\,\\ glucose\\ 107\\,\\ k\\ 5\\.1\\,\\ na\\ 136\\,\\ gfr\\ nml\\,\\ tsh\\ nml\\,\\ all\\ remaining\\ labs\\ within\\ normal\\ limits\ \(0\)\
\-\ physical\\ therapy\ \(90\)\
\-\ nsaids\\ as\\ tolerated\ \(0\)\
\-\ narcotics\\ for\\ pain\\ control\ \(0\)\
\-\ prophylactic\\ low\\ dose\\ colchicine\ \(0\)\
\-\ intraarticular\\ glucocorticoid\\ injections\ \(0\)\
\-\ aspiration\\ of\\ any\\ future\\ effusions\ \(0\)\
\-\ chondrocalcinosis\\ of\\ the\\ menisci\\ of\\ both\\ knees\\ with\\ severe\\ patellofemoral\\ joint\\ space\\ narrowing\\ bilaterally\\.\\ \\ medial\\ and\\ lateral\\ intraarticular\\ joint\\ spaces\\ are\\ preserved\\ bilaterally\\,\\ as\\ demonstrated\\ on\\ the\\ ap\\ radiograph\\.\\ a\\ suprapatellar\\ effusion\\ of\\ the\\ right\\ knee\\ is\\ present\\.\\ no\\ left\\ knee\\ effusion\\ is\\ seen\\.\ \(0\)\
\-\ calcium\\ pyrophosphate\\ dihydrate\\ \\(cppd\\)\\ crystal\\ deposition\\ disease\ \(0\)\
\-\ diseases\\ associated\\ with\\ cppd\ \(0\)\
\-\ gout\ \(75\)\
\-\ hyperparathyroidism\ \(35\)\
\-\ hemochromatosis\ \(13\)\
\-\ hypophosphatasia\ \(2\)\
\-\ hypothyroidism\ \(39\)\
\-\ neuropathic\\ osteoarthropathy\ \(3\)\
\-\ amyloidosis\ \(26\)\
\-\ long\\-term\\ corticosteroid\\ therapy\ \(0\)\
\-\ cc\\/hpi\\:\\ \\ 72\\ y\\/o\\ female\\ presents\\ with\\ history\\ of\\ several\\ weeks\\ bilateral\\ persistent\\ knee\\ pain\\ who\\ now\\ complains\\ of\\ an\\ increase\\ in\\ right\\ knee\\ pain\\ of\\ abrupt\\ onset\\ over\\ past\\ few\\ days\\.\\ \\ the\\ pain\\ is\\ minimally\\ relieved\\ with\\ percocet\\,\\ and\\ self\\-rated\\ as\\ 9\\/10\\.\\ \\ the\\ patient\\ denied\\ any\\ precipitating\\ trauma\\,\\ constitutional\\ symptoms\\ of\\ fatigue\\/fever\\/weight\\ change\\,\\ and\\ claims\\ no\\ arthralgias\\/myalgias\\/neuropathic\\ pain\\.\\ patient\\ has\\ swelling\\ and\\ warmth\\ associated\\ with\\ the\\ joint\\ pain\\.\\ \\ social\\ history\\ is\\ significant\\ for\\ a\\ positive\\ current\\ smoking\\ profile\\ and\\ no\\ etoh\\ use\\.\ \(0\)\
\-\ this\\ patient\\ with\\ cppd\\,\\ with\\ the\\ classic\\ linear\\ calcifications\\ in\\ the\\ menisci\\ of\\ both\\ knees\\ and\\ the\\ osteoarthritic\\ changes\\ at\\ the\\ patellofemoral\\ joint\\,\\ should\\ be\\ compared\\ against\\ the\\ radiographic\\ findings\\ in\\ hadd\\,\\ with\\ more\\ dense\\ calcifications\\,\\ so\\ one\\ may\\ appreciate\\ the\\ difference\\ between\\ the\\ two\\ pathologic\\ processes\\ on\\ plain\\ film\\.\ \(0\)\
\-\ \\ \\ \\ \\ with\\ this\\ patient\\'s\\ history\\ of\\ stomach\\ cancer\\ and\\ her\\ age\\,\\ nsaids\\ might\\ not\\ be\\ the\\ first\\ choice\\ for\\ treatment\\.\\ \\ intraarticular\\ steroid\\ injections\\ in\\ conjunction\\ with\\ aspiration\\ of\\ effusion\\ \\(right\\ knee\\)\\ could\\ providelocal\\ disease\\ control\\.\ \(0\)\
\-\ \\ \\ \\ \\ although\\ this\\ patient\\'s\\ temperature\\ was\\ normal\\ and\\ crystal\\ arthropathies\\ are\\ more\\ prevalent\\ in\\ an\\ older\\ population\\,\\ an\\ important\\ diagnosis\\ to\\ rule\\ out\\ is\\ septic\\ arthritis\\.\\ \\ if\\ the\\ patient\\ was\\ febrile\\ with\\ elevated\\ wbc\\ count\\ and\\ the\\ knees\\ was\\ warm\\ with\\ erythema\\,\\ infection\\ could\\ be\\ considered\\,\\ \\ and\\ joint\\ aspiration\\ may\\ be\\ done\\ with\\ subsequent\\ treatment\\ if\\ infection\\ present\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ knee\\:\\ 0\\.2558579602300828\ \(0\)\
\-\ knees\\:\\ 0\\.21255720176855475\ \(0\)\
\-\ intraarticular\\:\\ 0\\.18572165106039976\ \(0\)\
\-\ pain\\:\\ 0\\.18247157523316954\ \(0\)\
\-\ cppd\\:\\ 0\\.169466380907145\ \(0\)\
\-\ joint\\:\\ 0\\.16800870701194037\ \(0\)\
\-\ the\\:\\ 0\\.16279909018889646\ \(0\)\
\-\ with\\:\\ 0\\.14977588469696632\ \(0\)\
\-\ aspiration\\:\\ 0\\.13375017827983562\ \(0\)\
\-\ no\\:\\ 0\\.13265864160150087\ \(0\)\
\-\ patellofemoral\\:\\ 0\\.1238144340402665\ \(0\)\
\-\ menisci\\:\\ 0\\.1228477889606135\ \(0\)\
\-\ nml\\:\\ 0\\.1210584389534226\ \(0\)\
\-\ crystal\\:\\ 0\\.12022672718495464\ \(0\)\
\-\ neuropathic\\:\\ 0\\.1194319928420114\ \(0\)\
\-\ patient\\:\\ 0\\.1160981487862977\ \(0\)\
\-\ warmth\\:\\ 0\\.11591509233219036\ \(0\)\
\-\ effusion\\:\\ 0\\.11359880057353217\ \(0\)\
\-\ injections\\:\\ 0\\.1124438587153156\ \(0\)\
\-\ of\\:\\ 0\\.10977006119236961\ \(0\)\
\-\ and\\:\\ 0\\.10537070779818623\ \(0\)\
\-\ nsaids\\:\\ 0\\.09979036639372987\ \(0\)\
\-\ rom\\:\\ 0\\.0964875831600755\ \(0\)\
\-\ erythema\\:\\ 0\\.09228397630285724\ \(0\)\
\-\ control\\:\\ 0\\.087140629681625\ \(0\)\
\-\ be\\:\\ 0\\.08274322035516772\ \(0\)\
\-\ providelocal\\:\\ 0\\.08154884346841478\ \(0\)\
\-\ arthropathies\\:\\ 0\\.07535260020103633\ \(0\)\
\-\ calcifications\\:\\ 0\\.07443169986176665\ \(0\)\
\-\ could\\:\\ 0\\.07418251702855853\ \(0\)\
\-\ urate\\:\\ 0\\.07335785541051056\ \(0\)\
\-\ colchicine\\:\\ 0\\.07035003270085206\ \(0\)\
\-\ glucocorticoid\\:\\ 0\\.07035003270085206\ \(0\)\
\-\ percocet\\:\\ 0\\.07035003270085206\ \(0\)\
\-\ hadd\\:\\ 0\\.07035003270085206\ \(0\)\
\-\ is\\:\\ 0\\.06982384205225024\ \(0\)\
\-\ swelling\\:\\ 0\\.0686415123969972\ \(0\)\
\-\ gfr\\:\\ 0\\.06810346028751169\ \(0\)\
\-\ appreciate\\:\\ 0\\.06810346028751169\ \(0\)\
\-\ bilaterally\\:\\ 0\\.06801725919752032\ \(0\)\
\-\ narcotics\\:\\ 0\\.06716161214313211\ \(0\)\
\-\ hypophosphatasia\\:\\ 0\\.06630960685985576\ \(0\)\
\-\ precipitating\\:\\ 0\\.06630960685985576\ \(0\)\
\-\ claims\\:\\ 0\\.06630960685985576\ \(0\)\
\-\ any\\:\\ 0\\.06591146590522792\ \(0\)\
\-\ dihydrate\\:\\ 0\\.06553178697689557\ \(0\)\
\-\ prevalent\\:\\ 0\\.06553178697689557\ \(0\)\
\-\ osteoarthropathy\\:\\ 0\\.06415378943347362\ \(0\)\
\-\ suprapatellar\\:\\ 0\\.06353704218636978\ \(0\)\
\-\ in\\:\\ 0\\.06342696698326296\ \(0\)\
\-\ infection\\:\\ 0\\.06160539636888771\ \(0\)\
\-\ as\\:\\ 0\\.0614570447932136\ \(0\)\
\-\ 136\\:\\ 0\\.06142389448030675\ \(0\)\
\-\ osteoarthritic\\:\\ 0\\.06142389448030675\ \(0\)\
\-\ hemochromatosis\\:\\ 0\\.06096536887575366\ \(0\)\
\-\ conjunction\\:\\ 0\\.0605292194767113\ \(0\)\
\-\ ambulation\\:\\ 0\\.06011336359247732\ \(0\)\
\-\ lt\\:\\ 0\\.06011336359247732\ \(0\)\
\-\ 107\\:\\ 0\\.06011336359247732\ \(0\)\
\-\ chondrocalcinosis\\:\\ 0\\.06011336359247732\ \(0\)\
\-\ pyrophosphate\\:\\ 0\\.0597159964210057\ \(0\)\
\-\ ana\\:\\ 0\\.05933554370951713\ \(0\)\
\-\ difference\\:\\ 0\\.05933554370951713\ \(0\)\
\-\ if\\:\\ 0\\.05925635335326582\ \(0\)\
\-\ etoh\\:\\ 0\\.058620018778543254\ \(0\)\
\-\ therapy\\:\\ 0\\.058597524982494834\ \(0\)\
\-\ an\\:\\ 0\\.0584986096495079\ \(0\)\
\-\ history\\:\\ 0\\.05844678766564917\ \(0\)\
\-\ constitutional\\:\\ 0\\.05828264706337093\ \(0\)\
\-\ profile\\:\\ 0\\.05828264706337093\ \(0\)\
\-\ corticosteroid\\:\\ 0\\.057643854701681575\ \(0\)\
\-\ rt\\:\\ 0\\.05734079891899134\ \(0\)\
\-\ warm\\:\\ 0\\.057047681202287426\ \(0\)\
\-\ both\\:\\ 0\\.05687235772294515\ \(0\)\
\-\ tolerated\\:\\ 0\\.05676387039890101\ \(0\)\
\-\ amyloidosis\\:\\ 0\\.0562219293576578\ \(0\)\
\-\ more\\:\\ 0\\.05600117769954667\ \(0\)\
\-\ abrupt\\:\\ 0\\.05596280137556939\ \(0\)\
\-\ prophylactic\\:\\ 0\\.055710973752754814\ \(0\)\
\-\ physical\\:\\ 0\\.055299106484051196\ \(0\)\
\-\ associated\\:\\ 0\\.053754227223341576\ \(0\)\
\-\ preserved\\:\\ 0\\.05351975315362726\ \(0\)\
\-\ relieved\\:\\ 0\\.05351975315362726\ \(0\)\
\-\ was\\:\\ 0\\.05331465373766784\ \(0\)\
\-\ hypothyroidism\\:\\ 0\\.05313930044213869\ \(0\)\
\-\ social\\:\\ 0\\.052954978665910896\ \(0\)\
\-\ this\\:\\ 0\\.05256629759483128\ \(0\)\
\-\ febrile\\:\\ 0\\.05242377551116481\ \(0\)\
\-\ present\\:\\ 0\\.052332287465472714\ \(0\)\
\-\ might\\:\\ 0\\.05208640379599249\ \(0\)\
\-\ temperature\\:\\ 0\\.05192237553457309\ \(0\)\
\-\ pertinent\\:\\ 0\\.051761302898716735\ \(0\)\
\-\ against\\:\\ 0\\.05160308125616599\ \(0\)\
\-\ deposition\\:\\ 0\\.05144761143430313\ \(0\)\
\-\ gout\\:\\ 0\\.05144761143430313\ \(0\)\
\-\ may\\:\\ 0\\.051322530286636484\ \(0\)\
\-\ future\\:\\ 0\\.0511445556516129\ \(0\)\
\-\ to\\:\\ 0\\.050992558855688846\ \(0\)\
\-\ right\\:\\ 0\\.0507188278694716\ \(0\)\
\-\ processes\\:\\ 0\\.0501581224301021\ \(0\)\
\-\ touch\\:\\ 0\\.05002568609027936\ \(0\)\
\-\ glucose\\:\\ 0\\.049269803124914434\ \(0\)\
\-\ tsh\\:\\ 0\\.049269803124914434\ \(0\)\
\-\ 72\\:\\ 0\\.04914981086108711\ \(0\)\
\-\ steroid\\:\\ 0\\.04914981086108711\ \(0\)\
\-\ generalized\\:\\ 0\\.04868532771587101\ \(0\)\
\-\ treatment\\:\\ 0\\.04858130478251437\ \(0\)\
\-\ hyperparathyroidism\\:\\ 0\\.04857288234099678\ \(0\)\
\-\ remaining\\:\\ 0\\.04846183383923017\ \(0\)\
\-\ septic\\:\\ 0\\.04846183383923017\ \(0\)\
\-\ na\\:\\ 0\\.0483521479301701\ \(0\)\
\-\ minimally\\:\\ 0\\.0483521479301701\ \(0\)\
\-\ choice\\:\\ 0\\.0483521479301701\ \(0\)\
\-\ population\\:\\ 0\\.04824379158003775\ \(0\)\
\-\ factor\\:\\ 0\\.047823041477540816\ \(0\)\
\-\ effusions\\:\\ 0\\.047720877057720434\ \(0\)\
\-\ dose\\:\\ 0\\.047619867062830175\ \(0\)\
\-\ protein\\:\\ 0\\.04732350988624882\ \(0\)\
\-\ older\\:\\ 0\\.04732350988624882\ \(0\)\
\-\ smoking\\:\\ 0\\.04722686797814666\ \(0\)\
\-\ diseases\\:\\ 0\\.04685042122210671\ \(0\)\
\-\ esr\\:\\ 0\\.04666798041157423\ \(0\)\
\-\ has\\:\\ 0\\.046584196194940634\ \(0\)\
\-\ spaces\\:\\ 0\\.04640111613351704\ \(0\)\
\-\ for\\:\\ 0\\.046366724025525045\ \(0\)\
\-\ calcium\\:\\ 0\\.04605725491574829\ \(0\)\
\-\ denied\\:\\ 0\\.04605725491574829\ \(0\)\
\-\ rheumatoid\\:\\ 0\\.044948312384234454\ \(0\)\
\-\ dense\\:\\ 0\\.044948312384234454\ \(0\)\
\-\ current\\:\\ 0\\.04465519466753054\ \(0\)\
\-\ complains\\:\\ 0\\.04437138386414413\ \(0\)\
\-\ 65\\:\\ 0\\.04363439604306632\ \(0\)\
\-\ few\\:\\ 0\\.0432566233763989\ \(0\)\
\-\ important\\:\\ 0\\.04319518471920073\ \(0\)\
\-\ so\\:\\ 0\\.042894170103189994\ \(0\)\
\-\ disease\\:\\ 0\\.04281006573333497\ \(0\)\
\-\ stomach\\:\\ 0\\.042545842032394386\ \(0\)\
\-\ count\\:\\ 0\\.042101562310432335\ \(0\)\
\-\ pathologic\\:\\ 0\\.04178226803202523\ \(0\)\
\-\ normal\\:\\ 0\\.04164016689856709\ \(0\)\
\-\ arthritis\\:\\ 0\\.04147398612265356\ \(0\)\
\-\ compared\\:\\ 0\\.04122496474360209\ \(0\)\
\-\ linear\\:\\ 0\\.0410788150670102\ \(0\)\
\-\ increase\\:\\ 0\\.04093501642577343\ \(0\)\
\-\ done\\:\\ 0\\.04056249213115402\ \(0\)\
\-\ nodules\\:\\ 0\\.04051699946587705\ \(0\)\
\-\ rule\\:\\ 0\\.040471737144195795\ \(0\)\
\-\ limits\\:\\ 0\\.040292945395632135\ \(0\)\
\-\ full\\:\\ 0\\.03986101164836985\ \(0\)\
\-\ considered\\:\\ 0\\.03973539895717474\ \(0\)\
\-\ narrowing\\:\\ 0\\.0395298889998162\ \(0\)\
\-\ persistent\\:\\ 0\\.03928935549023358\ \(0\)\
\-\ use\\:\\ 0\\.03901667628356831\ \(0\)\
\-\ are\\:\\ 0\\.03869901798191559\ \(0\)\
\-\ change\\:\\ 0\\.03864102061508941\ \(0\)\
\-\ subsequent\\:\\ 0\\.038604308902572354\ \(0\)\
\-\ classic\\:\\ 0\\.03814028952169108\ \(0\)\
\-\ film\\:\\ 0\\.03810557379093821\ \(0\)\
\-\ radiographic\\:\\ 0\\.03783259717798715\ \(0\)\
\-\ studies\\:\\ 0\\.037406054754005894\ \(0\)\
\-\ weakness\\:\\ 0\\.037215849930883324\ \(0\)\
\-\ laboratory\\:\\ 0\\.03702960799796595\ \(0\)\
\-\ ap\\:\\ 0\\.03660956411204657\ \(0\)\
\-\ muscle\\:\\ 0\\.03620837482574412\ \(0\)\
\-\ extension\\:\\ 0\\.03609698036954979\ \(0\)\
\-\ wbc\\:\\ 0\\.03604179939535635\ \(0\)\
\-\ labs\\:\\ 0\\.03532839052296355\ \(0\)\
\-\ now\\:\\ 0\\.035004196661296505\ \(0\)\
\-\ elevated\\:\\ 0\\.034762579535804444\ \(0\)\
\-\ although\\:\\ 0\\.034715030011810054\ \(0\)\
\-\ first\\:\\ 0\\.034411974229119825\ \(0\)\
\-\ palpation\\:\\ 0\\.034389082310248724\ \(0\)\
\-\ showed\\:\\ 0\\.03396491660488743\ \(0\)\
\-\ cancer\\:\\ 0\\.03396491660488743\ \(0\)\
\-\ space\\:\\ 0\\.033943140005972115\ \(0\)\
\-\ plain\\:\\ 0\\.0336437099744709\ \(0\)\
\-\ positive\\:\\ 0\\.03360174140238808\ \(0\)\
\-\ out\\:\\ 0\\.03351839078049659\ \(0\)\
\-\ several\\:\\ 0\\.03345638389996782\ \(0\)\
\-\ should\\:\\ 0\\.03327290287515697\ \(0\)\
\-\ radiograph\\:\\ 0\\.03321256998404043\ \(0\)\
\-\ medial\\:\\ 0\\.0331925491706684\ \(0\)\
\-\ past\\:\\ 0\\.0331925491706684\ \(0\)\
\-\ between\\:\\ 0\\.033132754369567904\ \(0\)\
\-\ onset\\:\\ 0\\.032744028367869195\ \(0\)\
\-\ examination\\:\\ 0\\.0326306320553382\ \(0\)\
\-\ severe\\:\\ 0\\.03228074908629156\ \(0\)\
\-\ days\\:\\ 0\\.03228074908629156\ \(0\)\
\-\ some\\:\\ 0\\.0320842732776898\ \(0\)\
\-\ age\\:\\ 0\\.03201388480823437\ \(0\)\
\-\ her\\:\\ 0\\.031857508410696685\ \(0\)\
\-\ decreased\\:\\ 0\\.03158608598376841\ \(0\)\
\-\ demonstrated\\:\\ 0\\.031338900941911975\ \(0\)\
\-\ changes\\:\\ 0\\.030818018307189273\ \(0\)\
\-\ on\\:\\ 0\\.03080149810895265\ \(0\)\
\-\ weeks\\:\\ 0\\.030561081058951788\ \(0\)\
\-\ all\\:\\ 0\\.030354893908347676\ \(0\)\
\-\ two\\:\\ 0\\.030282393191118005\ \(0\)\
\-\ secondary\\:\\ 0\\.030224813027889017\ \(0\)\
\-\ trauma\\:\\ 0\\.029614764386894057\ \(0\)\
\-\ significant\\:\\ 0\\.029442211497618248\ \(0\)\
\-\ low\\:\\ 0\\.02926003626706868\ \(0\)\
\-\ one\\:\\ 0\\.029195863059427545\ \(0\)\
\-\ who\\:\\ 0\\.028844765893850727\ \(0\)\
\-\ over\\:\\ 0\\.028354327372624923\ \(0\)\
\-\ symptoms\\:\\ 0\\.02790045886087525\ \(0\)\
\-\ bilateral\\:\\ 0\\.027405498135009636\ \(0\)\
\-\ diagnosis\\:\\ 0\\.02643438878795976\ \(0\)\
\-\ lateral\\:\\ 0\\.025306685935952932\ \(0\)\
\-\ findings\\:\\ 0\\.025167070860669227\ \(0\)\
\-\ female\\:\\ 0\\.024606454917065413\ \(0\)\
\-\ presents\\:\\ 0\\.02453024567942252\ \(0\)\
\-\ seen\\:\\ 0\\.024007072460930458\ \(0\)\
\-\ within\\:\\ 0\\.023485784713277606\ \(0\)\
\-\ not\\:\\ 0\\.020130807422285634\ \(0\)\
\-\ at\\:\\ 0\\.019260686363755913\ \(0\)\
\-\ left\\:\\ 0\\.01739481064813266\ \(0\)\
